Dr. Eugene Muchnik

Abdalla Sholi, MD, specializes in hematology oncology and medical oncology and is board-certified in medical oncology by the American Board of Internal Medicine. He is affiliated with UPMC Williamsport, UPMC Wellsboro and UPMC Cole. Dr. Sholi completed his residencies in primary care and internal medicine at Scranton-Temple Residency Program and medical degree at the University of Jordan. Dr. Sholi is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Inflammatory Breast Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC).

David Greenwald is a Hematologist Oncology specialist and a Hematologist in Kingston, Pennsylvania. Dr. Greenwald is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Childhood Iron Deficiency Anemia, Gastroesophageal Junction Cancer, and Bone Marrow Aspiration.

Rajiv Panikkar, MD, is the chair of the Geisinger Cancer Institute.|Dr. Panikkar was raised in Bloomsburg, Pa. He received his Doctor of Medicine degree from the University of Pittsburgh. He completed his residency in internal medicine at Virginia Commonwealth University Hospital, where he served as chief medical resident. His hematology/oncology fellowship was at Temple University Hospital/Fox Chase Cancer Center. He is board certified in hematology and oncology, and he practices as a medical oncologist.|Dr. Panikkar came to Geisinger in 2008 as a medical oncologist at Geisinger Medical Center. As chair of the Geisinger Cancer Institute, he currently leads 11 hematology/oncology, 6 radiation oncology and 4 palliative medicine sites across Pennsylvania. He is the principal investigator for Geisinger’s National Cancer Institute Community Research Program, a collaborative network designed to conduct oncology clinical trials and generate new knowledge through cancer care delivery research.|“The Geisinger Cancer Institute has an amazing opportunity to provide compassionate, patient-focused care close to home. We are expanding clinical trial opportunities and providing new medications and new technology to our communities. Our commitment to a team approach allows us to bring highly trained physicians together who are focused on the patient. Working at Geisinger is special — it has given me the opportunity to care for families I grew up with. I am excited about the growth of comprehensive services for the patients in our region."". Dr. Panikkar is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Arterial Embolism, and Familial Colorectal Cancer.